On 26 April I wrote: > If you look more closely at the Disclosure list it is evident an error has > occurred: > > Peter D. Kramer, MD > Clinical Professor, Department of Psychiatry and Human Behavior, Brown > University. > Disclosure: Thomas Kramer, MD, has disclosed that he receives funding for > clinical grants from Pfizer, Eli Lilly, Abbott, and Janssen. He holds > consulting agreements with Pfizer, Eli Lilly, Glaxo, and Wyeth-Ayerst. > > It would appear that the author for whom the disclosure is being made is > Peter D. Kramer, Brown University, not Thomas A. M. Kramer, Northwestern > University, Chicago. It looks as if whoever is responsible for preparing > the disclosure list may have mistakenly written "Thomas Kramer" in the > disclosure statement beneath the name Peter D. Kramer, MD.
Bill Scott replied: > The article was written by Thomas AM Kramer. I will await the information > you receive from medscape. Yes, Bill, the article was written by Thomas A. M. Kramer, but the fact that the Disclosures page listed three authors� names indicated it was not merely providing a disclosure specifically for the article in question. Nevertheless, I agree that if there had been no anomaly it would have been clear that the Kramer disclosure related to the author of the article which linked to that disclosure page. But I remind you that that particular disclosure note read as follows: Peter D. Kramer, MD Clinical Professor, Department of Psychiatry and Human Behavior, Brown University. Disclosure: Thomas Kramer, MD, has disclosed that he receives funding for clinical grants from Pfizer, Eli Lilly, Abbott, and Janssen. He holds consulting agreements with Pfizer, Eli Lilly, Glaxo, and Wyeth-Ayerst. As the author in question has the name Thomas A. M. Kramer, I would have thought that it would have been immediately apparent that something was wrong somewhere. This remains the case regardless of the outcome of my inquiry to Medscape. Allen Esterson Former lecturer, Science Department Southwark College, London [EMAIL PROTECTED] http://www.human-nature.com/esterson/index.html http://www.butterfliesandwheels.com/articleprint.php?num=10 Mon, 26 Apr 2004 05:53:35 -0400 Author: "Allen Esterson" <[EMAIL PROTECTED]> Subject: Re: Suicide / Antidepressant > On 26 April Bill Scott wrote: > > > Okay, Allen, you make me do my homework. > > Regarding the issues below, this is from Medscape: Go to one of Thomas AM > > Kramer's CME articles at medscape such as: > > http://www.medscape.com/viewarticle/420839 > > > > Then click on "disclosures" at the top of the page. You will find the > > following. > > > > Disclosure: Thomas Kramer, MD, has disclosed that he receives funding for > > clinical grants from Pfizer, Eli Lilly, Abbott, and Janssen. He holds > > consulting agreements with Pfizer, Eli Lilly, Glaxo, and Wyeth-Ayerst. > > > > Now I am no longer just highly suspicious that he is well funded by the drug > > companies, I "am sure". Still, thanks for making me provide the evidence for > > my conjectures. > > > I checked http://www.medscape.com/viewarticle/420839 and found the > article: > > Antidepressant Response and Noradrenaline > Disclosures > > Thomas Kramer, MD > > > I then clicked �Disclosures� and found the following: > > 42nd Annual Scientific Meeting of the American Headache Society > Clinical Features and Guidelines > > Faculty and Disclosures > > Authors > Martin L. Korn, MD > Private Practice, New York City, NY > Disclosure: Martin L. Korn, MD, has disclosed that he has discussed the > unlabeled use of topiramate, gabapentin, lamotragine, and carbamazapine in > the treatment of bipolar disorder. > > Peter D. Kramer, MD > Clinical Professor, Department of Psychiatry and Human Behavior, Brown > University. > Disclosure: Thomas Kramer, MD, has disclosed that he receives funding for > clinical grants from Pfizer, Eli Lilly, Abbott, and Janssen. He holds > consulting agreements with Pfizer, Eli Lilly, Glaxo, and Wyeth-Ayerst. > > Takuya Saito, MD, PhD > Assistant Professor, Department of Psychiatry, Albert Einstein College of > Medicine, Bronx, New York. > Disclosure: Takuya Saito, MD, has no significant financial interests to > disclose. > > > As three Authors are cited, and from the heading, it is evident that the > �Disclosures� are for the Meeting as a whole, not specifically for the > article �Strategies and Tactics in the Medication Management of > Depression� by Thomas Kramer, MD. > > If you look more closely at the Disclosure list it is evident an error has > occurred: > > Peter D. Kramer, MD > Clinical Professor, Department of Psychiatry and Human Behavior, Brown > University. > Disclosure: Thomas Kramer, MD, has disclosed that he receives funding for > clinical grants from Pfizer, Eli Lilly, Abbott, and Janssen. He holds > consulting agreements with Pfizer, Eli Lilly, Glaxo, and Wyeth-Ayerst. > > It would appear that the author for whom the disclosure is being made is > Peter D. Kramer, Brown University, not Thomas A. M. Kramer, Northwestern > University, Chicago. It looks as if whoever is responsible for preparing > the disclosure list may have mistakenly written "Thomas Kramer" in the > disclosure statement beneath the name Peter D. Kramer, MD. > > That "Thomas Kramer" is the likely error (not, the author cited, Peter D. > Kramer) is suggested from the previous named author, Martin L. Korn, MD. > In the disclosure statement the name Martin L. Korn, MD is repeated in > full, unlike in the case of Peter D. Kramer. Evidently the full name of > the author is always given in the disclosure statement, whereas in that > beneath Peter D. Kramer the shortened name "Thomas Kramer" is given. My > guess is that whoever wrote the disclaimer statement for Peter D. Kramer > confused the author of the article "Antidepressant Response and > Noradrenaline" (Thomas Kramer) with Peter D. Kramer, and wrote the wrong > name under the latter�s disclosure information. > > But I hope all will be revealed after I receive a response from the > Medscape site director, to whom I have sent an e-mail asking him to > clarify this anomaly. > > Allen Esterson > Former lecturer, Science Department > Southwark College, London > [EMAIL PROTECTED] > > http://www.human-nature.com/esterson/index.html > http://www.butterfliesandwheels.com/articleprint.php?num=10 --- You are currently subscribed to tips as: [EMAIL PROTECTED] To unsubscribe send a blank email to [EMAIL PROTECTED]
